If/when AFFY solves the issue with Omontys, this will once again be a $27.00 stock just like last year......no doubt in my mind,
Just got in for 20,000 shares @ $1.29 shares, and I'm going to ride it out one way or the other.
Look at this recently FDA Approved drug of ONXX........the side affects.
Stivarga is being approved with a Boxed Warning alerting patients and health care professionals that severe and fatal liver toxicity occurred in patients treated with Stivarga during clinical studies. Serious side effects, which occurred in less than one percent of patients, were liver damage, severe bleeding, blistering and peeling of skin, very high blood pressures requiring emergency treatment, heart attacks and perforations (holes) in the intestines. The most common side effects reported in patients treated with Stivarga include weakness or fatigue, loss of appetite, hand-foot syndrome (also called palmar-plantar erythrodysesthesia), diarrhea, mouth sores (mucositis), weight loss, infection, high blood pressure, and changes in voice volume or quality (dysphonia).
Yea...but nobody died. Patients died on the Affymax drug....that's a HUGE difference. Mark my words, the FDA will make an example out of this company. Is it fair...probably not....its just that everyone once in a while the FDA just loves to send a message to the street!
There is no silver bullet, they all have moderate to severe side effects including death. I am locked and loaded and will ride past $15. All we need is news, until then there is accumulation and some small day traders flipping pennies, but when news comes in then watch out!
Hi ezqi I didn't see the Motley article, I got that info. from Wikipedia about the drug Stivarga and it's horrendous side effects,.........and it's FDA Approved.
Just indicating to me that there is an excellent possibility this deal with Omontys will be rectified.
I mean look at the facts, Fresenius Medical felt comfortable with continuing on with the drug.....it was AFFY that pulled it, so as to investigate where the problem is. For all we know it was some new inexperienced employee at the dialysis center that was not indoctrinated properly. Or something totally not connected with the drug itself.